Summary: Planmeca has introduced the Planmeca Viso G3 to the North American market, a versatile CBCT device for 2D and 3D extraoral imaging. This addition completes the Viso lineup and offers advanced features such as Ultra Low Dose protocol and motion artifact correction, enhancing patient safety and image quality.
Key Takeaways:
- Expanded Product Line: Planmeca Viso G3 joins the Viso G7 and G5, providing comprehensive CBCT imaging solutions.
- Advanced Safety Features: The Viso G3 includes Ultra Low Dose protocol and motion artifact correction to minimize radiation exposure.
Planmeca has expanded its imaging line to include the Planmeca Viso G3 for the North American market – a multifunctional CBCT device for 2D and 3D extraoral imaging.
The Planmeca Viso G3 completes Planmeca’s CBCT lineup alongside the Viso G7 and Viso G5 – all powered by all-in-one Planmeca Romexis dental software.
Introduction of the Viso G3
“We are thrilled to offer this addition to our highly regarded Viso product line,” said Glen Kendrick, Planmeca USA president. “With all the benefits of Planmeca Viso technology, the Viso G3 allows clinics desiring a 3D with fantastic usability and outstanding image quality to be introduced to the superiority of Planmeca CBCT imaging.”
Versatile Imaging Capabilities
The device is designed for diverse clinics and clinical needs, from endodontics to implantology. With a Field of View (FOV) ranging from 3 x 3 to 20 x 10 cm, the it offers 3D images of the full dentition and the capacity to capture detailed panoramic images and bitewing images for detailed diagnosis of interproximal caries.
Advanced Safety and Usability Features
Planmeca Viso G3 has advanced features designed to ensure patient safety. These include the Planmeca Ultra Low Dose protocol to reduce effective patient dose without a statistical reduction in image quality. Additionally, the proprietary Planmeca CALM algorithm for motion artifact correction can be applied both before and after acquisition to reduce the need for retakes, limiting radiation exposure.
The Planmeca Viso G3 includes freely adjustable 3D volume size and anatomical target selection. The patient positioning programs, which include a live video view and virtual FOV adjustments, prioritize a patient comfort workflow, according to the company.
Upgradability and Expanded Capabilities
The Planmeca Viso G3 can also be upgraded to Planmeca Viso G5 for a larger maximum 3D volume, to meet the needs of an expanding practice. Additionally, expanded treatment capability is available with the addition of the Planmeca ProCeph one-shot cephalostat.